Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Background: We assessed the potential efficacy of Coenzyme Q10 (CoQ10) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Methods: Seventy STEMI patients who presented ≤12 hours after the onset of symptoms and were schedu...
Saved in:
Main Authors: | Amirhossein Yazdi (Author), Kimia Shirmohammadi (Author), Erfan Parvaneh (Author), Seyed Kianoosh Hosseini (Author), Akram Ranjbar (Author), Maryam Mehrpooya (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE RELATIONSHIP OF GENDER WITH IMMEDIATE RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION
by: N. Netyazhenko, et al.
Published: (2015) -
Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
by: Göksel Çinier, et al.
Published: (2020) -
Citicoline Modifies the Expression of Specific miRNAs Related to Cardioprotection in Patients with ST-Segment Elevation Myocardial Infarction Subjected to Coronary Angioplasty
by: Alejandro Silva-Palacios, et al.
Published: (2022) -
PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
by: Wu ZF, et al.
Published: (2023) -
Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020)